| 000 | 01476 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250515074954.0 | ||
| 264 | 0 | _c20080215 | |
| 008 | 200802s 0 0 eng d | ||
| 022 | _a0012-186X | ||
| 024 | 7 |
_a10.1007/s00125-007-0751-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHiukka, A | |
| 245 | 0 | 0 |
_aLong-term effects of fenofibrate on VLDL and HDL subspecies in participants with type 2 diabetes mellitus. _h[electronic resource] |
| 260 |
_bDiabetologia _cOct 2007 |
||
| 300 |
_a2067-75 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCholesterol _xblood |
| 650 | 0 | 4 |
_aCholesterol, HDL _xblood |
| 650 | 0 | 4 |
_aCholesterol, LDL _xblood |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFenofibrate _xtherapeutic use |
| 650 | 0 | 4 |
_aHomocysteine _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypolipidemic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aLipoproteins, HDL _xblood |
| 650 | 0 | 4 |
_aLipoproteins, VLDL _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPlacebos |
| 700 | 1 | _aLeinonen, E | |
| 700 | 1 | _aJauhiainen, M | |
| 700 | 1 | _aSundvall, J | |
| 700 | 1 | _aEhnholm, C | |
| 700 | 1 | _aKeech, A C | |
| 700 | 1 | _aTaskinen, M R | |
| 773 | 0 |
_tDiabetologia _gvol. 50 _gno. 10 _gp. 2067-75 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00125-007-0751-8 _zAvailable from publisher's website |
| 999 |
_c17187484 _d17187484 |
||